Brief: IBT Continues Development Of Drug Candidate IBP-9414
Dec 20 (Reuters) - Infant Bacterial Therapeutics AB
IBTb.ST :
* IBT CONTINUES DEVELOPMENT OF DRUG CANDIDATE IBP-9414
* WILL CONTINUE TOWARDS LAUNCH OF DRUG IBP-9414 AS SOON AS
POSSIBLE
Source text: ID:nMFN5XHy8B
Further company coverage: IBTb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Infant Bacterial Therapeutics AB
See all newsBrief: Infant Bacterial Therapeutics Gets FDA Request For Type B Pre-BLA Meeting
Brief: Infant Bacterial Therapeutics Q2 Operating Loss Widens To SEK 30.1 Mln
Brief: Infant Bacterial Therapeutics CFO Leaves The Company
Brief: Infant Bacterial Announces Phase III IBP-9414 Study Results
Brief: Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln